Affimed N.V. (NASDAQ:AFMD) announced topline data from its phase 2 REDIRECT study of AFM13 monotherapy in patients with advanced-stage relapsed/refractory peripheral…
Companies Reporting Before The Bell
• Alkaline Water Co (NASDAQ:WTER) is likely to report quarterly loss at $0.05 per share on revenue of $18.31 million.